Zaino R J, Kurman R J, Diana K L, Morrow C P
Department of Pathology, Milton S. Hershey Medical Center of Pennsylvania State University, Hershey.
Cancer. 1995 Jan 1;75(1):81-6. doi: 10.1002/1097-0142(19950101)75:1<81::aid-cncr2820750114>3.0.co;2-f.
The histologic grade of endometrial adenocarcinoma is related to the aggressiveness of the tumor and probability of death from disease. However, the ideal system for assignment of histologic grade remains controversial. In 1988, the International Federation of Gynecology and Obstetrics (FIGO) revised its recommendations for grading typical endometrial adenocarcinoma, such that grade is determined primarily by the architecture of the tumor and secondarily modified in the presence of "notable nuclear atypia"; this phrase, however, has never been defined, and therefore the prognostic validity of this system is unknown.
Seven hundred and fifteen women with clinical Stage I and occult Stage II endometrial adenocarcinomas (excluding serous or clear cell type) entered on a Gynecologic Oncology Group protocol, and those treated by total abdominal hysterectomy, bilateral salpingo-oophorectomy, and selective pelvic and para-aortic lymph node sampling formed the study population. All cases were centrally reviewed and assigned an architectural grade and a nuclear grade using specific criteria. The FIGO grade was then determined. The various grading methods were examined based on ability to stratify patients into groups with differing rates of disease progression and relative survival at five years.
The architectural grade, nuclear grade, and FIGO grade of tumors each were used to separate patients into groups with statistically significant different rates of progression of disease and relative survival. The FIGO modification of architectural grade resulted in the reassignment of 44 patients into a higher grade. The outcome for these 44 was worse than for the remaining patients in the initial grade but was similar to the group into which they were moved.
If clearly specified criteria for architectural and nuclear grading are used and "notable nuclear atypia" is defined as grade 3 nuclei, the 1988 FIGO grading system has prognostic utility. The authors recommend this system as the standard method for the grading of typical endometrial adenocarcinoma.
子宫内膜腺癌的组织学分级与肿瘤的侵袭性及疾病致死概率相关。然而,理想的组织学分级系统仍存在争议。1988年,国际妇产科联盟(FIGO)修订了其对典型子宫内膜腺癌分级的建议,即分级主要依据肿瘤的结构,并在存在“显著核异型性”时进行次要调整;然而,该术语从未被定义,因此该系统的预后有效性尚不清楚。
715例临床分期为I期和隐匿性II期的子宫内膜腺癌(不包括浆液性或透明细胞型)患者进入妇科肿瘤学组方案,接受全腹子宫切除术、双侧输卵管卵巢切除术及选择性盆腔和腹主动脉旁淋巴结取样的患者构成研究人群。所有病例均进行集中审查,并使用特定标准确定结构分级和核分级。然后确定FIGO分级。根据将患者分层为疾病进展率和五年相对生存率不同的组的能力,对各种分级方法进行了检验。
肿瘤的结构分级、核分级和FIGO分级均用于将患者分为疾病进展率和相对生存率有统计学显著差异的组。FIGO对结构分级的修改导致44例患者被重新分配到更高的级别。这44例患者的结局比初始级别中的其余患者更差,但与他们被重新分配到的组相似。
如果使用明确规定的结构和核分级标准,并将“显著核异型性”定义为3级核,则1988年FIGO分级系统具有预后价值。作者推荐该系统作为典型子宫内膜腺癌分级的标准方法。